Try our Advanced Search for more refined results

Q&A

Q&A With Sullivan & Cromwell's Matthew Hurd

Law360, New York (July 16, 2012, 1:58 PM EDT) -- Matthew Hurd is a partner in Sullivan & Cromwell LLP's New York office. As co-head of the firm's health care and life sciences practice with nearly 20 years focused on its development, he advises domestic and international clients on mergers and acquisitions and complex investment transactions in pharmaceuticals, biotechnology, medical devices, and health care insurance and benefits. In 2011, he acted for Medco Health Solutions Inc. in its $34.3 billion acquisition by Express Scripts Inc., and Pharmasset Inc. in its $11 billion acquisition by Gilead Sciences Inc....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!